Healthy volunteers needed to test drug interaction for schizophrenia treatment
NCT ID NCT07305779
First seen Jan 08, 2026 · Last updated May 24, 2026 · Updated 21 times
Summary
This study looked at how a drug called quinidine changes the way the body processes SEP-380135, a potential schizophrenia treatment. Twelve healthy adults took a single dose of SEP-380135 with and without quinidine to measure drug levels and safety. The goal was to understand possible drug interactions, not to treat schizophrenia directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.